Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

319
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
319
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

6.4K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
6.4K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.5K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

1.1K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.1K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

227
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
227
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

2.1K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Neural Control of Tissue Perfusion: Emerging Evidence and Beyond.

Current hypertension reports·2026
Same journal

Correction to: Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
Same journal

Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease.

Current hypertension reports·2026
Same journal

Combined Aldosterone Synthase and SGLT2 Inhibition: A Recipe for Success in CKD with Uncontrolled Blood Pressure?

Current hypertension reports·2026
Same journal

Leveraging the Electronic Health Record to Identify and Manage Resistant Hypertension.

Current hypertension reports·2026
Same journal

Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
See all related articles

Related Experiment Video

Updated: Dec 10, 2025

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
06:51

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device

Published on: July 29, 2016

8.2K

AI (Artificial Intelligence) and Hypertension Research.

Franco B Mueller1

  • 1Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, 318 West 100th Street, Box 8D, New York, NY, 10025, USA. francobm6@gmail.com.

Current Hypertension Reports
|August 28, 2020
PubMed
Summary
This summary is machine-generated.

Integrating artificial intelligence (AI) with genome and RNA sequencing is crucial for advancing hypertension research. This approach will unlock new biological insights and potential precision medicine treatments for hypertension.

Keywords:
Artificial intelligenceCancer and hypertension research publicationsDeep machine learning algorithmsGene and protein networksHypertension treatmentTarget moleculesWhole genome and RNA sequencing

More Related Videos

Long-term Blood Pressure Measurement in Freely Moving Mice Using Telemetry
07:54

Long-term Blood Pressure Measurement in Freely Moving Mice Using Telemetry

Published on: May 17, 2016

21.4K
Simultaneous Electrocardiography Recording and Invasive Blood Pressure Measurement in Rats
07:35

Simultaneous Electrocardiography Recording and Invasive Blood Pressure Measurement in Rats

Published on: January 31, 2019

16.1K

Related Experiment Videos

Last Updated: Dec 10, 2025

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
06:51

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device

Published on: July 29, 2016

8.2K
Long-term Blood Pressure Measurement in Freely Moving Mice Using Telemetry
07:54

Long-term Blood Pressure Measurement in Freely Moving Mice Using Telemetry

Published on: May 17, 2016

21.4K
Simultaneous Electrocardiography Recording and Invasive Blood Pressure Measurement in Rats
07:35

Simultaneous Electrocardiography Recording and Invasive Blood Pressure Measurement in Rats

Published on: January 31, 2019

16.1K

Area of Science:

  • Genomics and Bioinformatics
  • Cardiovascular Research
  • Artificial Intelligence in Medicine

Background:

  • Essential hypertension research and management have seen limited progress.
  • Human genome sequencing has yielded powerful research tools, yet hypertension studies lag behind cancer research in utilizing them.
  • DNA and RNA sequencing offer opportunities to understand complex biological networks in hypertension, similar to their application in cancer research.

Purpose of the Study:

  • To highlight the necessity of integrating artificial intelligence (AI) with advanced sequencing technologies for hypertension research.
  • To emphasize the potential of AI and sequencing to uncover novel biological mechanisms and therapeutic targets in hypertension.
  • To advocate for a foundational shift in hypertension research methodology.

Main Methods:

  • Leveraging genome and RNA sequencing technologies on a broad scale.
  • Applying AI tools to analyze large datasets from sequencing and clinical information.
  • Comparing the utilization of sequencing tools in hypertension research versus cancer research.

Main Results:

  • Cancer research has significantly benefited from large-scale DNA and RNA sequencing, leading to improved understanding and clinical applications.
  • Hypertension studies using sequencing tools represent less than 2% of cancer studies, indicating a significant gap.
  • AI combined with sequencing data can generate hypotheses, discover mechanisms, and identify potential drug targets for hypertension.

Conclusions:

  • Effective use of AI in hypertension research requires a strong foundation in understanding hypertension biology through broad-scale genome and RNA sequencing.
  • Without integrating sequencing-based tools, AI applications in hypertension may yield limited or questionable results, hindering precision medicine.
  • Advancing hypertension research and management necessitates adopting gene sequencing-based tools and AI analytics to overcome stagnation and achieve precision medicine goals.